16.03.2016
- AstraZeneca shareholders are said to be questioning the £8.4 million pay package awarded to CEO executive Pascal Soriot last year after he successfully deflected a hostile bid from...
29.10.2012
- Struggling British drugmaker AstraZeneca is giving its new chief executive Pascal Soriot 4 million pounds ($6.44 million) compensation for loss of long-term incentives from his...
28.08.2012
- AstraZeneca has poached Pascal Soriot from rival Roche Holding to be its new chief executive, hoping his track record in drug innovation and dealmaking can revive a company...
01.06.2012
- AstraZeneca's new chairman took the helm on Friday and said the troubled drugmaker faced "a period of significant change". Leif Johansson's first priority is to find a permanent...
26.04.2012
- AstraZeneca Chief Executive David Brennan is to step down on June 1 in an abrupt exit after six years in the top job, following rising investor discontent at the company's...
23.04.2012
- AstraZeneca has agreed to buy U.S. company Ardea Biosciences for $1.26 billion, giving it a new gout drug to bolster its weak pipeline in a deal that feeds a wave of M&A in the...
21.06.2011
- Anglo-Swedish drug company AstraZeneca is in final talks to sell its Swedish healthcare and dental business Astra Tech to Dentsply International in a deal that could value the...
